https://www.memphis.edu/research/development/parrilllab.pdf
rational
drug
discovery
protein
modeling
representative
publication
gacasan
baker
parrill
protein
coupled
receptor
evolution
structural
insight
aim
biophysics
ragle
palanisamy
joe
stein
norman
tigyi
baker
parrill
discovery
synthetic
optimization
novel
scaffold
hydrophobic
tunnel
targeted
autotaxin
inhibition
bioorg
med
chem
mcmillan
bukiya
terrell
patil
miller
dopico
parrill
multi
generational
pharmacophore
modeling
ligand
cholanesteroid
recognition
site
modulatory
subunit
bkcachannel
mol
graph
model
doi
jmgm
valentine
godwin
osborne
liu
fujiwara
van
brocklyn
bittman
parrill
tigyi
fty
gilenya
phosphate
selectivity
sphingosine
phosphate
receptor
subtype
protein
coupled
receptor
requires
motif
intracellular
loop
transmembrane
domain
biol
chem
http
www
jbc
org
cgi
doi
jbc
fell
tsukahara
liu
tigyi
parrill
structure
based
drug
design
identifies
novel
lpa
antagonist
bioorg
med
chem
jo
sanna
gonzalez
cabrera
thangada
tigyi
osborne
hla
parrill
rosen
selective
vivo
active
agonist
high
throughput
screening
shelf
chemical
probe
receptor
interaction
signaling
fate
chemistry
biology
yuan
parrill
cluster
analysis
three
dimensional
qsar
study
hiv
integrase
inhibitor
mol
graphic
model
structure
baseddrug
discovery
ligand
based
drug
discovery
information
please
contact
abby
parrill
ph
aparrill
memphis
edu
membersoftherationaldrugdiscoveryandprotein
modelinglabutilizeasuiteofcomputationalmedicinal
chemistryandproteinmodelingtechniquestoprioritize
candidatesforexperimentalstudiesintheearly
stagedrug
discoveryprocess
thisteamisledbyprofessorof
chemistryandassociatedeaninthecollegeofartsand
science
abbyparrill
research
interest
expertise
dr
parrill
sgroupapproachesthedrugdiscovery
processthroughtheuseofcomputationalmethodstoguide
investmentsoftimeandresourcesintoexperimental
studiesthataremostlikelytoidentifycandidatedrugswith
thedesiredbiologicalactivity
computationalpharmacophoremodelscanidentifytheligandfeaturesand
geometryrequiredforrecognitionofabiologicaltarget
quantitativestructureactivitymodelsareappliedtopredict
potenciesofcandidatecompounds
thesetypesofmethods
areligand
baseddrugdiscoverymethods
notrequiring
knowledgeofthebiologicaltargetstructure
additionalcomputationaltechniquessuchasdockingdo
requirethree
dimensionalstructuraldetailsaboutthe
biologicaltarget
suchdetailscancomefromexperimental
structuralbiologyapproaches
butcanalsocomefrom
proteinmodelingeffortswhenexperimentalstructural
informationisnotavailable
theparrillgroupspecializesin
modelingmembraneproteins
particularmembersoftheg
protein
coupledreceptorfamily
whichserveastargetsfor
offda
approveddrugsonthemarket
dr
parrill
researchissupportedbythenationalinstitutesofhealth
